PROCEPT BioRobotics Corporation (PRCT) Profit Margins
Over the twelve months to 2026-06-30, PROCEPT BioRobotics Corporation (PRCT) had gross margin 64.2%, operating margin -33.9%, net margin -32.5%, free cash flow margin -25.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PRCTPROCEPT BioRobotics CorporationFollow PRCT — free
—
Price chart with a free account
- Market cap
- 1.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Gross margin | 46.0% | 49.4% | 52.2% | 61.1% | 63.7% | 64.2% | |
| Operating margin | -157.1% | -107.6% | -80.2% | -43.0% | -33.7% | -33.9% | |
| Net margin | -173.6% | -116.2% | -77.8% | -40.7% | -31.0% | -32.5% | |
| FCF margin | -168.0% | -110.7% | -97.8% | -46.2% | -18.9% | -25.2% |
USD millions · SEC XBRL
PROCEPT BioRobotics Corporation — questions
- What is PROCEPT BioRobotics Corporation's gross margin?
- 64.2% over the twelve months to 2026-06-30.
- What is PROCEPT BioRobotics Corporation's operating margin?
- -33.9% over the twelve months to 2026-06-30.
- What is PROCEPT BioRobotics Corporation's net profit margin?
- -32.5% over the twelve months to 2026-06-30.
Every figure on this page comes from PROCEPT BioRobotics Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.